Retraction

The PI3K/mTOR Dual Inhibitor BEZ235 Nanoparticles Improve Radiosensitization of Hepatoma Cells Through Apoptosis and Regulation DNA Repair Pathway

Paper Information

Record ID:
34815
Publication Date:
March 26, 2020
Retraction Date:
December 16, 2021 (3.9 years years ago)
Article Type:
Publisher:
Springer
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:

Retraction Details

Nature of Retraction:

Retraction

Retraction Notice:
10.1186/s11671-021-03638-4
Additional Notes:

see also: https://pubpeer.com/publications/72A5F1223FAFA05C0A6C879BC9C5CD;

Citations (18)

18
Total Citations
10
Post-Retraction
(55.6%)
8
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
3 Within 30 days
3 Within 1 year
5 After 2+ years
1135 Days since retraction (latest)
Recent advances in polymeric nanoparticles for the treatment of hepatic diseases
Feng Gao, Xuefei Feng, Xinyu Li
Frontiers in Pharmacology Open Access
Published: Jan 2025
4 citations
1135 days after retraction
Cutting-Edge Nanotechnology in Oncology Therapy Advancements and Application
P. Selvakumar, Varsha D. Satav, A.R. Reddy et al. (5 authors)
Advances in chemical and materials engineering book series
Published: Oct 2024
1041 days after retraction
Targeted and Self-Adjuvated Nanoglycovaccine Candidate for Cancer Immunotherapy
Rui Freitas, Eduardo Ferreira, Andréia Miranda et al. (16 authors)
ACS Nano
Published: Mar 2024
5 citations
832 days after retraction
Dual-loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer
Mohamed El‐Tanani, Hamdi Nsairat, Alaa A. A. Aljabali et al. (6 authors)
Expert Opinion on Drug Delivery
Published: Jan 2024
8 citations
774 days after retraction
Novel Strategies for Overcoming Drug Resistance
Sameer Ullah Khan, Shariqa Jan, Kaneez Fatima et al. (4 authors)
Unknown Journal
Published: Jan 2024
746 days after retraction
The mTOR Signaling Pathway and mTOR Inhibitors in Cancer: Next-generation Inhibitors and Approaches
Murat Ihlamur, Buşra Akgül, Yağmur Zengin et al. (6 authors)
Current Molecular Medicine
Published: May 2023
18 citations
511 days after retraction
Recent advancement in nanomaterial-encapsulated drug delivery vehicles for combating cancer, COVID-19, and HIV-like chronic diseases
Suparna Paul, Subhajit Mukherjee, Priyabrata Banerjee
Materials Advances Open Access
Published: Jan 2023
18 citations
381 days after retraction
Engineering nanomedicines to inhibit hypoxia-inducible Factor-1 for cancer therapy
Xiaojuan Zhang, Chuanchuan He, Guangya Xiang
Cancer Letters
Published: Jan 2022
21 citations
30 days after retraction
Therapeutic Uses of TheraCour™ Polymeric Nanomicelles Against Cancer, Infectious Diseases, and More
Anil Diwan, Jayant Tatake, Ashok Chakraborty
Springer eBooks
Published: Jan 2022
1 citation
16 days after retraction
Nanotechnology-based targeted delivery systems for protein kinase inhibitors in Cancer therapy
Disha Mittal, Karishma Niveria, Anita Verma
Elsevier eBooks
Published: Jan 2022
2 citations
16 days after retraction
Molecular mechanisms involved in DNA repair in human cancers: An overview of PI3k/Akt signaling and PIKKs crosstalk
Forough Alemi, Aydin Raei Sadigh, Faezeh Malakoti et al. (10 authors)
Journal of Cellular Physiology
Published: Sep 2021
26 citations
94 days before retraction
LY‑294002 enhances the chemosensitivity of liver cancer to oxaliplatin by blocking the PI3K/AKT/HIF‑1α pathway
Ruyue Xu, Yinci Zhang, Amin Li et al. (10 authors)
Molecular Medicine Reports Open Access
Published: May 2021
23 citations
219 days before retraction
Synergistic Anticancer Strategy of Sonodynamic Therapy Combined with PI-103 Against Hepatocellular Carcinoma
Huajing Yang, Hui Jing, Xue Han et al. (5 authors)
Drug Design Development and Therapy Open Access
Published: Feb 2021
18 citations
318 days before retraction
Hypoxia-induced therapy resistance: Available hypoxia-targeting strategies and current advances in head and neck cancer
Victoria L. Codony, Mahvash Tavassoli
Translational Oncology Open Access
Published: Jan 2021
58 citations
332 days before retraction
Stereotactic Radiotherapy for Hepatocellular Carcinoma, Radiosensitization Strategies and Radiation-Immunotherapy Combination
Luís A. Pérez-Romasanta, E. González Del Portillo, A. Rodríguez-Gutierrez et al. (4 authors)
Cancers Open Access
Published: Jan 2021
38 citations
343 days before retraction
LY3214996 relieves acquired resistance to sorafenib in hepatocellular carcinoma cells
Yongfang Ma, Ruyue Xu, Xueke Liu et al. (11 authors)
International Journal of Medical Sciences Open Access
Published: Jan 2021
30 citations
349 days before retraction
Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma
Fanhua Kong, Qifa Ye, Xiongying Miao et al. (8 authors)
Theranostics Open Access
Published: Jan 2021
153 citations
349 days before retraction
Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance
Yihan Yao, Yunxiang Zhou, Lihong Liu et al. (10 authors)
Frontiers in Molecular Biosciences Open Access
Published: Aug 2020
1090 citations
483 days before retraction
Quick Stats
Total Citations: 18
Years Since Retraction: 3.9 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
Single-wall carbon nanohorns inhibited activation of microg…
Discover Nano (formerly known as Nanoscale Research Letters) • 11 citations
HDAC1-Mediated MicroRNA-124-5p Regulates NPY to Affect Lear…
Discover Nano (formerly known as Nanoscale Research Letters) • 12 citations
Long non-coding RNA H19 deteriorates hypoxic-ischemic brain…
Discover Nano (formerly known as Nanoscale Research Letters) • 5 citations
Down-regulation of microRNA-342-5p or Up-regulation of Wnt3…
Discover Nano (formerly known as Nanoscale Research Letters) • 11 citations
LINC01354/microRNA-216b/KRAS Axis Promotes the Occurrence a…
Discover Nano (formerly known as Nanoscale Research Letters) • 8 citations